Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Operating Income: 2020-2024

Historic Operating Income for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to -$128.4 million.

  • Arcutis Biotherapeutics' Operating Income rose 121.82% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.2 million, marking a year-over-year increase of 78.98%. This contributed to the annual value of -$128.4 million for FY2024, which is 46.75% up from last year.
  • According to the latest figures from FY2024, Arcutis Biotherapeutics' Operating Income is -$128.4 million, which was up 46.75% from -$241.1 million recorded in FY2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Operating Income peaked at -$128.4 million during FY2024, and registered a low of -$301.6 million during FY2022.
  • For the 3-year period, Arcutis Biotherapeutics' Operating Income averaged around -$223.7 million, with its median value being -$241.1 million (2023).
  • In the last 5 years, Arcutis Biotherapeutics' Operating Income plummeted by 51.14% in 2021 and then soared by 46.75% in 2024.
  • Yearly analysis of 5 years shows Arcutis Biotherapeutics' Operating Income stood at -$136.6 million in 2020, then slumped by 51.14% to -$206.5 million in 2021, then plummeted by 46.05% to -$301.6 million in 2022, then climbed by 20.07% to -$241.1 million in 2023, then skyrocketed by 46.75% to -$128.4 million in 2024.